Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
207.4 USD | +0.31% |
|
-1.09% | -12.29% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.29% | 10.65B | |
+21.85% | 46.93B | |
+37.63% | 39.08B | |
-8.05% | 38.48B | |
+29.04% | 31.01B | |
-13.75% | 26.14B | |
+10.65% | 25.88B | |
+38.43% | 12.53B | |
-6.92% | 11.36B | |
-8.20% | 9.04B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- UBS Adjusts Charles River Laboratories International Price Target to $270 From $215, Maintains Buy Rating